ArticlePloS one2019

Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.

Elżbieta Jabłonowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.